Endothelial microparticles as conveyors of information in atherosclerotic disease
Autor: | Fiona L. Wilkinson, Ferdinand Serracino-Inglott, Ria Weston, J.V. Smyth, Michelle Alexander, Andrew Schiro |
---|---|
Rok vydání: | 2014 |
Předmět: |
Pathology
medicine.medical_specialty Endothelium Inflammation Disease Asymptomatic Pathogenesis Cell-Derived Microparticles medicine Animals Humans Endothelial dysfunction Stroke business.industry Endothelial Cells Atherosclerosis Prognosis medicine.disease medicine.anatomical_structure Inflammation Mediators medicine.symptom Cardiology and Cardiovascular Medicine business Cell activation Biomarkers Signal Transduction |
Zdroj: | Atherosclerosis. 234:295-302 |
ISSN: | 0021-9150 |
DOI: | 10.1016/j.atherosclerosis.2014.03.019 |
Popis: | Endothelial microparticles (EMPs) are complex submicron membrane-shed vesicles released into the circulation following endothelium cell activation or apoptosis. They are classified as either physiological or pathological, with anticoagulant or pro-inflammatory effects respectively. Endothelial dysfunction caused by inflammation is a key initiating event in atherosclerotic plaque formation. Athero-emboli, resulting from ruptured carotid plaques are a major cause of stroke. Current clinical techniques for arterial assessment, angiography and carotid ultrasound, give accurate information about stenosis but limited evidence on plaque composition, inflammation or vulnerability; as a result, patients with asymptomatic, or fragile carotid lesions, may not be identified and treated effectively. There is a need to discover novel biomarkers and develop more efficient diagnostic approaches in order to stratify patients at most risk of stroke, who would benefit from interventional surgery. Increasing evidence suggests that EMPs play an important role in the pathogenesis of cardiovascular disease, acting as a marker of damage, either exacerbating disease progression or triggering a repair response. In this regard, it has been suggested that EMPs have the potential to act as biomarkers of disease status. In this review, we will present the evidence to support this hypothesis and propose a novel concept for the development of a diagnostic device that could be implemented in the clinic. |
Databáze: | OpenAIRE |
Externí odkaz: |